Your browser doesn't support javascript.
loading
Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects.
Gaudy, Allison; Atsriku, Christian; Ye, Ying; MacGorman, Kimberly; Liu, Liangang; Xue, Yongjun; Surapaneni, Sekhar; Palmisano, Maria.
Afiliação
  • Gaudy A; Clinical Pharmacology, Bristol Myers Squibb, Princeton, NJ, USA. Allison.Gaudy@bms.com.
  • Atsriku C; Nonclinical Development, Bristol Myers Squibb, Princeton, NJ, USA.
  • Ye Y; Clinical Pharmacology, Bristol Myers Squibb, Princeton, NJ, USA.
  • MacGorman K; Clinical Pharmacology, Bristol Myers Squibb, Princeton, NJ, USA.
  • Liu L; Global Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, NJ, USA.
  • Xue Y; Nonclinical Development, Bristol Myers Squibb, Princeton, NJ, USA.
  • Surapaneni S; Nonclinical Development, Bristol Myers Squibb, Princeton, NJ, USA.
  • Palmisano M; Clinical Pharmacology, Bristol Myers Squibb, Princeton, NJ, USA.
Eur J Clin Pharmacol ; 77(2): 223-231, 2021 Feb.
Article em En | MEDLINE | ID: mdl-32965548
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article